Concepedia

Zahi Mitri

ZM

28

Publications

1.4K

Citations

18

H-Index

2010

Active since

Affiliations

Oregon Health & Science University(Current)

The University of Texas MD Anderson Cancer Center

OHSU Knight Cancer Institute

University of Pennsylvania

American University of Beirut

Zahi Mitri is an author at Oregon Health & Science University specializing in medicine, breast cancer, and oncology.

ORCID

Top concepts

Publications per year

2010–2023

28

Publications

28

The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy

Zahi Mitri, Tina Constantine, Ruth O’Regan · Chemotherapy Research and Practice · 2012 · 515 citations · Full text

A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer

Zahi Mitri, Cansu Karakaş, Caimiao Wei et al. · Investigational New Drugs · 2015 · 88 citations

, , +9

Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors

Matthew S. Dietz, Thomas L. Sutton, Brett S. Walker et al. · Scientific Reports · 2021 · 73 citations · Full text

, , +17

Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy

Madeline Cook, Luai Al Rabadi, Andy Kaempf et al. · The Oncologist · 2020 · 56 citations · Full text

CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real‐world practice

Malinda West, Claire E.P. Smith, Andy Kaempf et al. · European Journal Of Haematology · 2021 · 55 citations · Full text

Rows per page

1–5 of 28